Deutsche Bank falls foul of the FSA and pays the price with a £6 million fine

LOSSES & LAWSUITS

According to the regulator, these breaches arose from two separate transactions conducted by Deutsche during March 2004. The first was in relation to a book build in Scania AB B class shares, while the second involved the stabilisation of Cytos Biotechnology shares.

In addition, the FSA has also imposed a financial penalty of £350,000 on David Maslen, Deutsche's former head of European cash trading, for being knowingly concerned in the failure to observe proper standards of market conduct in the Scania transaction.

The fines are in keeping with the FSA's new focus on enforcement, especially in the market abuse arena. Hector Sants, FSA managing director for wholesale business said in a statement: "The FSA has previously expressed a determination to act against institutional market misconduct and Deutsche's failure is an example of the type of conduct which the FSA will act against in its efforts to improve the overall quality of markets." OR&C

  • LinkedIn  
  • Save this article
  • Print this page  

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: